Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Organisation › Details

Avacta (Group)

Avacta’s principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal’s immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. *

 

Period Start 2007-11-14 existent
Products Industry analytical instrument
  Industry 2 diagnostics (medical/biological)
     
Region Region Leeds, West Yorkshire
  Country United Kingdom (GB)
  Street Ash Way, Unit 20
Thorp Arch Estate
  City LS23 7FA Wetherby
  Tel +44-1904-21-7070
    Address record changed: 2024-05-09
     
Basic data Employees n. a.
     
    * Document for »About Section«: Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva.
     
   
Record changed: 2024-05-09

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Avacta (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px




» top